Learn / REPL
NASDAQ: REPL
Replimune Group (REPL) stock, explained like you're 5
Replimune Group trades on the Nasdaq under the ticker REPL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.3 billion dollars.
- Ticker
- REPL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.3 billion dollars
Is Replimune Group a small, medium or large cap company?
No. Replimune Group is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Replimune Group makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves REPL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Is REPL Stock Soaring 127% After Hours Today? (Stocktwits)
- REPL Nov 2026 10.500 call (REPL261106C00010500) stock historical prices and data (Yahoo Finance UK)
- Why Did REPL, SNOW, NET Stocks Surge To 52 Week Highs Last Week? (Stocktwits)
- Replimune Group: A Hold Until TUDRIQEV’s Commercial Potential Becomes Clear (NASDAQ:REPL) (Seeking Alpha)
- REPL Deadline Alert: SueWallSt Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026 (Morningstar)
Follow REPL in your daily brief
Each trading day at 5 PM ET we post what happened to Replimune Group and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow REPL
Questions about Replimune Group stock
What does Replimune Group do?
Replimune Group trades on the Nasdaq under the ticker REPL. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.3 billion dollars.
What is the ticker symbol for Replimune Group?
Replimune Group trades under the ticker REPL on the Nasdaq.
What is Replimune Group's market cap?
Replimune Group is a small cap stock with a market cap of about 1.3 billion dollars.
How does Replimune Group make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves REPL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow REPL stock every day?
Add REPL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.